What are the newer-generation therapies for treating facial acne, including topical retinoids, benzoyl‑peroxide, dapsone, isotretinoin, tetracyclines, spironolactone, and procedural options?

New Therapies for Facial Acne

For mild-to-moderate acne, start with fixed-dose combination topical retinoid plus benzoyl peroxide, and for moderate-to-severe acne, use fixed-dose combination topical retinoid plus benzoyl peroxide with oral doxycycline or proceed directly to isotretinoin if there is scarring or psychosocial burden. 1

Topical Therapies: The Foundation

First-Line Topical Agents

The 2024 American Academy of Dermatology guidelines strongly recommend multimodal topical therapy combining multiple mechanisms of action 1. The cornerstone agents include:

• Topical retinoids (strong recommendation, moderate certainty): These are essential for both treatment and maintenance 1. The newest retinoid, trifarotene, specifically targets retinoic acid receptor-gamma and offers improved tolerability 2, 3.

• Benzoyl peroxide (strong recommendation, moderate certainty): FDA-approved at 5% and 10% concentrations 4, this remains critical for preventing antibiotic resistance and should be used concomitantly with any antibiotic therapy 1.

• Fixed-dose combinations are strongly preferred over monotherapy:

  • Retinoid + benzoyl peroxide (strong recommendation) 1
  • Retinoid + topical antibiotic (strong recommendation, but must include benzoyl peroxide to prevent resistance) 1
  • Antibiotic + benzoyl peroxide (strong recommendation) 1

Newer Topical Options

Clascoterone represents a genuinely novel mechanism—the first topical androgen receptor antagonist for acne (conditional recommendation, high certainty evidence) 1, 2, 3. This addresses hormonal pathogenesis directly at the sebaceous gland level.

Azelaic acid (conditional recommendation, moderate certainty) and salicylic acid (conditional recommendation, low certainty) provide alternatives, though evidence is weaker 1.

Important caveat: Topical antibiotic monotherapy is explicitly not recommended due to resistance concerns 1.

Systemic Therapies: For Moderate-to-Severe Disease

Oral Antibiotics

When topical therapy is insufficient, systemic antibiotics are indicated, but guidelines emphasize limiting duration to reduce resistance 1:

• Doxycycline (strong recommendation, moderate certainty) is preferred 1
• Sarecycline (conditional recommendation, high certainty)—a newer narrow-spectrum tetracycline with potentially fewer side effects 2, 3
• Minocycline (conditional recommendation, moderate certainty) 1

Critical practice point: Systemic antibiotics must be used concomitantly with benzoyl peroxide and other topical therapy—never as monotherapy 1.

Hormonal Therapies

For appropriate patients (those who can become pregnant):

• Spironolactone (conditional recommendation, moderate certainty): Potassium monitoring is not needed in healthy patients without risk factors for hyperkalemia 1. Recent evidence challenges older monitoring conventions 3.

• Combined oral contraceptives (conditional recommendation, moderate certainty) 1

Isotretinoin: The Most Effective Option

Isotretinoin is recommended for severe acne or treatment-refractory cases, and patients with psychosocial burden or scarring should be considered candidates regardless of traditional severity classification 1, 5.

Key updates from 2024 guidelines 1:

• Monitor only liver function tests and lipids (not complete blood counts in healthy patients)
• Daily dosing is preferred over intermittent dosing
• Either lidose-isotretinoin (newer micronized formulation with improved absorption) or standard isotretinoin is acceptable 1, 2
• Population-based studies have not identified increased risk of neuropsychiatric conditions or inflammatory bowel disease 1

FDA warnings remain important 5: Visual problems require immediate discontinuation and ophthalmologic evaluation. Pregnancy prevention is mandatory for those of childbearing potential. Bone density effects and premature epiphyseal closure are concerns, particularly with multiple courses.

Procedural Options

For patients seeking non-pharmacologic approaches or adjunctive therapy:

• Chemical peels (salicylic acid, mandelic acid): Showed 39.70% improvement in mild-to-moderate acne 6
• Photochemical therapy (combined blue/red light): 35.36% improvement for mild-to-moderate acne 6
• Photodynamic therapy: 40.45% improvement for moderate-to-severe acne 6
• Intralesional corticosteroids (good practice statement): Recommended as adjuvant for larger papules/nodules at risk of scarring, using lower concentrations to minimize adverse effects 1

Important limitation: Evidence quality for procedural therapies is lower with high uncertainty, though findings appear robust 6.

Emerging Therapies on the Horizon

Novel approaches under investigation include 2, 7:

• Bacteriophages targeting Cutibacterium acnes
• Probiotics and microbiome modulators
• Antimicrobial peptides
• Insulin-like growth factor modulators
• Cannabidiol formulations

These remain experimental and are not yet ready for clinical practice.

Practical Algorithm

For mild-to-moderate acne:

1. Start fixed-dose topical retinoid + benzoyl peroxide
2. If inadequate response after 6-8 weeks, add topical antibiotic (with continued benzoyl peroxide)
3. Consider chemical peels or photochemical therapy as adjuncts

For moderate-to-severe acne:

1. Start fixed-dose topical retinoid + benzoyl peroxide PLUS oral doxycycline
2. If scarring or significant psychosocial burden exists, proceed directly to isotretinoin
3. For females, consider spironolactone or combined oral contraceptives
4. Limit oral antibiotic duration; transition to maintenance with topical retinoids

Common pitfall: Patients often discontinue therapy prematurely. Counsel that treatments require 6-8 weeks to demonstrate efficacy and that maintenance therapy with topical retinoids prevents recurrence 1, 8.